Showing 1 - 2 of 2 Graft Failure
A PHASE 3, OPEN-LABEL, RANDOMIZED, STANDARD OF CARE-CONTROLLED, PARALLEL ARM STUDY TO DEMONSTRATE EFFICACY AND SAFETY OF ARINA-1 IN THE PREVENTION OF BRONCHIOLITIS OBLITERANS SYNDROME PROGRESSION IN PARTICIPANTS WITH BILATERAL LUNG TRANSPLANT

Status: Enrolling

Investigator: Howard Huang

Study Coordinator: Darrel Cleere

Phone: 713.441.6232

The goal of this clinical trial is to compare ARINA-1 plus Standard of Care vs Standard of Care alone. The main question it aims to answer are: Evaluate the effectiveness of ARINA-1 in preventing bronchiolitis obliterans syndrome (BOS) progre ... Read more >

Observational Registry Study with Sub-analysis (Patients Previously Randomized to LAMBDA 001) to Assess ProsperaTM Performance for Detection of CLAD after Lung Transplant (LAMBDA 002)

Status: Enrolling

Investigator: Howard Huang

Study Coordinator: Mohanad Alhalboos

Phone: 832.455.9134

The LAMBDA 002 registry study is an observational, longitudinal, multi-center study observing patients undergoing lung transplant. ... Read more >